These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization. Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131 [TBL] [Abstract][Full Text] [Related]
3. Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study. Gangi A; Shah J; Hatfield N; Smith J; Sweeney J; Choi J; El-Haddad G; Biebel B; Parikh N; Arslan B; Hoffe SE; Frakes JM; Springett GM; Anaya DA; Malafa M; Chen DT; Chen Y; Kim RD; Shridhar R; Kis B J Vasc Interv Radiol; 2018 Aug; 29(8):1101-1108. PubMed ID: 30042074 [TBL] [Abstract][Full Text] [Related]
4. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346 [TBL] [Abstract][Full Text] [Related]
12. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience. Tohme S; Sukato D; Chen HW; Amesur N; Zajko AB; Humar A; Geller DA; Marsh JW; Tsung A J Vasc Interv Radiol; 2013 Nov; 24(11):1632-8. PubMed ID: 24160821 [TBL] [Abstract][Full Text] [Related]
13. Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort. Gupta AN; Gordon AC; Gabr A; Kalyan A; Kircher SM; Mahalingam D; Mulcahy MF; Merkow RP; Yang AD; Bentrem DJ; Caicedo-Ramirez JC; Riaz A; Thornburg B; Desai K; Sato KT; Hohlastos ES; Kulik L; Benson AB; Salem R; Lewandowski RJ Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1117-1128. PubMed ID: 35732931 [TBL] [Abstract][Full Text] [Related]
14. Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study. Rafi S; Piduru SM; El-Rayes B; Kauh JS; Kooby DA; Sarmiento JM; Kim HS Cardiovasc Intervent Radiol; 2013 Apr; 36(2):440-8. PubMed ID: 22956045 [TBL] [Abstract][Full Text] [Related]
15. Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study. White J; Carolan-Rees G; Dale M; Patrick HE; See TC; Bell JK; Manas DM; Crellin A; Slevin NJ; Sharma RA J Vasc Interv Radiol; 2019 Aug; 30(8):1185-1192. PubMed ID: 31255499 [TBL] [Abstract][Full Text] [Related]
16. Repeated Treatment with Filippi L; Di Costanzo GG; Tortora R; Pelle G; Cianni R; Schillaci O; Bagni O Cancer Biother Radiopharm; 2019 May; 34(4):231-237. PubMed ID: 30758985 [No Abstract] [Full Text] [Related]
17. Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Naïve Patients. Reimer P; Virarkar MK; Binnenhei M; Justinger M; Schön MR; Tatsch K Cardiovasc Intervent Radiol; 2018 May; 41(5):744-752. PubMed ID: 29344713 [TBL] [Abstract][Full Text] [Related]
18. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment. Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598 [TBL] [Abstract][Full Text] [Related]
19. Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study. Kis B; Shridhar R; Mhaskar R; Gyano M; Frakes JM; El-Haddad G; Choi J; Kim RD; Hoffe SE J Vasc Interv Radiol; 2023 Sep; 34(9):1547-1555. PubMed ID: 37210030 [TBL] [Abstract][Full Text] [Related]
20. Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study. Salem R; Johnson GE; Kim E; Riaz A; Bishay V; Boucher E; Fowers K; Lewandowski R; Padia SA Hepatology; 2021 Nov; 74(5):2342-2352. PubMed ID: 33739462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]